Chevron Left
Back to Drug Discovery

Learner Reviews & Feedback for Drug Discovery by University of California San Diego

4.6
stars
3,881 ratings

About the Course

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Discovery course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug discovery. In this course you will learn the drug discovery process up to the filing of an Initial New Drug Application or IND. Each week you will learn the steps that a pharmaceutical or biotech company goes through to discover a new therapeutic drug. In this course you will be able to: * Understand the pharmaceutical and biotechnology market a changing landscape * Learn the major aspects of the drug discovery process, starting with target selection, to compound screening to designing lead candidates. * Recognize current modern drug discovery based on the lock-and-key theory, which attempts to use one single compound to hit one target to combat the related disease. * Increase understanding of the various drug discovery tools and methods that are used for finding, identifying and designing a new drug. * Define and understand the regulatory responsibilities for drug discovery to file an Investigational New Drug Application (IND). This course is intended as part 1 of a series: Drug Discovery, Drug Development (https://www.coursera.org/learn/drug-development) and Drug Commercialization (https://www.coursera.org/learn/drug-commercialization). We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place....

Top reviews

KS

Aug 15, 2023

Great course, highly recommended. The course was well organized and the content relevant to my job role. It was delivered with great enthusiasm and the format ensured that it captured its audience.

KA

Jun 10, 2023

This course taught me about the nutshell procedure and process of drug discovery in biotech and pharma companies. I'm really grateful that this course explains very briefly and particularly.

Filter by:

526 - 550 of 773 Reviews for Drug Discovery

By Md S K

•

Sep 21, 2021

Good

By Siddhi M

•

Jul 7, 2021

100%

By Sahani j j

•

Apr 5, 2021

Good

By JEEVAN S M

•

Sep 25, 2020

Good

By Varsha K

•

Sep 15, 2020

good

By BOLIGARLA V C - 2 B

•

Sep 11, 2020

Good

By Anaswar U

•

Sep 11, 2020

Good

By GLORIYA V

•

Aug 23, 2020

Good

By Mariyam C

•

Aug 21, 2020

Best

By Uma M K

•

Jun 20, 2020

Good

By Dhobi N

•

Jun 10, 2020

Good

By potti d

•

May 28, 2020

good

By Abburu S

•

May 26, 2020

Good

By Ayush n

•

Apr 27, 2020

Good

By Gokul

•

Apr 23, 2020

good

By Vishnu d

•

Apr 23, 2020

Good

By Mohammad J S

•

Sep 23, 2017

good

By Aline B C A

•

Jul 15, 2022

...

By Galiger C

•

Jan 26, 2022

top

By Yashwanth G

•

Oct 15, 2020

...

By Emayamsavitha

•

Apr 27, 2020

Gud

By Avin M

•

Jul 8, 2021

😍

By 名宏 鄭

•

Aug 15, 2024

讚

By Lioba I C G

•

Jun 6, 2023

By ananda

•

Apr 30, 2021

This course holds up well and is still worth taking considering that there has been a great deal of change in the industry over the past 5+ years. The presenters in this course convey a high-level overview of the key components of drug development including screening, targeting and selection as well as PK/PD considerations and delivery options. Some of the presenters also go over very informative real world development case studies. That said, I hope they update the course sometime soon. This class is largely comprised of guest lectures giving live one-hour presentations to an audience. These presentations are broken up into smaller modules. Having more bespoke and discreet lectures probably allows for more content for a given amount of time (e.g., less redundancy and better sequencing). Also, the course is focused on small molecules. Biologics including gene therapy and editing, have become even more common in the past 5 years and merit more robust coverage. In my opinion, a course like this would start out with uniform concepts across all major drug modalities and then expand upon the specific considerations based on drug types (the Drug Discovery presenter in this class is a good example of this approach).